CDC Reports on Prevalence of Seasonal and Food Allergies, Eczema
18.9 percent of children and 25.7 percent of adults had seasonal allergy; 10.8 and 7.3 percent had eczema in 2021
Diagnosis & Disease Information
Odactra Approved for Adolescents With House Dust Mite Allergic Rhinitis
Odactra is an allergen extract indicated as immunotherapy for the treatment of HDM-induced allergic rhinitis.
Frequent Green Space Visits Linked to Lower Use of Certain Meds
Lower use of psychotropic, antihypertensive, and asthma medications observed; association attenuated by body mass index
Recommendations Updated for Management of Celiac Disease
Multiple biopsies of duodenum needed for diagnosis of celiac disease; upper endoscopy with intestinal biopsy useful for monitoring cases on gluten-free diet
Cannabis Legalization Tied to Increases in Pediatric Asthma
Increases seen compared with states where neither recreational nor medical legalization has occurred
MPR Weekly Dose Podcast Episode #144
FDA grant accelerated approval to Alzheimer disease treatment; New fixed-dose asthma treatment; NERD therapy looks promising; Leukemia drug to be withdrawn in 2023; Pertussis prevention treatment approved for use during pregnancy.
Prenatal Exposure to Acid-Suppressive Meds Not Linked to Allergic Disease
Association seen between infant exposure to acid-suppressive medications and increased asthma risk in offspring
FDA: Patients Should Be Cautious When Using Online Pharmacies to Buy Meds
Red flags include pharmacies that do not require a doctor’s prescription or have a licensed pharmacist to answer questions
Mepolizumab Shows Real-World Efficacy in Allergic and Non-Allergic Asthma
The researchers conducted a retrospective cohort study using claims data from the Optum Research Database for 538 patients at least 6 years of age who initiated mepolizumab treatment for asthma between January 2016 and December 2019.
Exacerbations Risk Exists for Patients With All Levels of Asthma Control/Severity
The researchers analyzed 351,870 US patients at least 12 years of age from the IBM MarketScan databases who received SABA for asthma from 2010 to 2017.
